Ticker Symbol: VOR
Vor Biopharma Inc
$17.30 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001817229
Company Profile
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: www.vorbiopharma.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.06
Change:
$0.11
(
5.63%)
Days Range: $1.89 - $2.10
Beta: 1.03
52wk. High: $7.57
52wk. Low: $1.89
Ytd. Change -64.97%
50 Day Moving Average: $2.25
200 Day Moving Average: $3.45
Shares Outstanding: 67538680
Valuation
Market Cap: 13.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A